rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2001-3-27
|
pubmed:abstractText |
Preeclampsia is believed to result from release of placental factors that damage maternal vascular endothelium. However, because most studies have been conducted during pregnancy, it has not been possible to separate maternal from placental mechanisms underlying endothelial dysfunction in preeclampsia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0098-7484
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
285
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1607-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11268269-Adult,
pubmed-meshheading:11268269-Antioxidants,
pubmed-meshheading:11268269-Ascorbic Acid,
pubmed-meshheading:11268269-Blood Flow Velocity,
pubmed-meshheading:11268269-Brachial Artery,
pubmed-meshheading:11268269-Case-Control Studies,
pubmed-meshheading:11268269-Endothelium, Vascular,
pubmed-meshheading:11268269-Female,
pubmed-meshheading:11268269-Humans,
pubmed-meshheading:11268269-Nitroglycerin,
pubmed-meshheading:11268269-Oxidative Stress,
pubmed-meshheading:11268269-Pre-Eclampsia,
pubmed-meshheading:11268269-Pregnancy,
pubmed-meshheading:11268269-Regional Blood Flow,
pubmed-meshheading:11268269-Risk Factors,
pubmed-meshheading:11268269-Vasodilation,
pubmed-meshheading:11268269-Vasodilator Agents
|
pubmed:year |
2001
|
pubmed:articleTitle |
Association of maternal endothelial dysfunction with preeclampsia.
|
pubmed:affiliation |
National Heart and Lung Institute, Imperial College School of Medicine, Hammersmith Hospital, London, England. j.kooner@ic.ac.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|